Indian Journal of Medical Microbiology Home 

ORIGINAL ARTICLE
[Download PDF]
Year : 2006  |  Volume : 24  |  Issue : 3  |  Page : 177--181

Molecular epidemiology of clinical isolates of AmpC producing Klebsiella pneumoniae

V Manchanda1, NP Singh1, A Shamweel2, HK Eideh2, SS Thukral2,  
1 Department of Microbiology, University College of Medical Sciences, New Delhi - 110095, India
2 VP Chest Institute, Delhi University, Delhi, India

Correspondence Address:
V Manchanda
Department of Microbiology, University College of Medical Sciences, New Delhi - 110095
India

Abstract

Purpose: AmpC producing K. pneumoniae have been increasingly reported from India but epidemiological studies are lacking. In the present study, molecular epidemiology of extended-spectrum AmpC beta-lactamases (ESACs) producing clinical isolates of K. pneumoniae prevalent in our hospital was studied. Methods: Fifty-one non-repeat, consecutive, clinical isolates of K. pneumoniae producing AmpC enzymes, were subjected to whole cell protein profile analysis (SDS-PAGE) and ribotyping. The antimicrobial susceptibility was determined using standard disk diffusion technique. The isolates showing decreased susceptibility to cefoxitin (<18 mm) or cefotetan (<16 mm) were subjected to modified three- dimensional test for detection of AmpC enzyme. Results: Six different types of protein profiles were observed. Ribotyping could further discriminate between the strains that were clustered by protein fingerprinting. Twelve different ribo-patterns were identified. Ribotyping was found to have a better Discriminatory Index (0.98) than that of SDS-PAGE (0.78). Of the 26 isolates that showed decreased susceptibility to cefoxitin and/or cefotetan 13 isolates were found to harbour AmpC enzyme. Conclusions: The study demonstrated the usefulness of SDS-PAGE whole cell protein profile analysis and ribotyping to identify the clonality of the ESACs isolates, the latter having a higher discriminatory power. The presence of ESACs isolates in the community as well as in hospital settings emphasizes the need for regular monitoring of antimicrobial resistance.

How to cite this article:
Manchanda V, Singh N P, Shamweel A, Eideh H K, Thukral S S. Molecular epidemiology of clinical isolates of AmpC producing Klebsiella pneumoniae .Indian J Med Microbiol 2006;24:177-181

How to cite this URL:
Manchanda V, Singh N P, Shamweel A, Eideh H K, Thukral S S. Molecular epidemiology of clinical isolates of AmpC producing Klebsiella pneumoniae . Indian J Med Microbiol [serial online] 2006 [cited 2020 Nov 25 ];24:177-181
Available from: https://www.ijmm.org/text.asp?2006/24/3/177/26990

Full Text

Clinical bacterial isolates producing AmpC enzymes are resistant to oxyimino group (ceftazidime, cefotaxime, ceftriaxone and cefuroxime) and the 7a - methoxy group (cefoxitin, cefotetan, cefmetazole and moxalactam) cephalosporins. Several epidemiological studies have shown that AmpC enzyme producing bacteria are recovered from hospitalized patients after several days of admission to the hospital.[1]-[3] Affected patients have often had prolonged stays in intensive care units. These patients had surgical problems and one or more underlying chronic diseases. Source of organisms included urine (about 50% of the isolates), blood, wound, sputum or stool. A majority of patients had been treated with beta-lactam antibiotics including cefoxitin, moxalactam, cefotetan or imipenem.[1],[4]

AmpC beta-lactamases are encountered most frequently in isolates of Klebsiella pneumoniae .[5] It is important to detect ESBLs producing as well as AmpC producing bacterial isolates since, there is a risk of the emergence of extended-spectrum AmpC beta-lactamases (ESACs).[6] Therefore, proper surveillance and epidemiological studies of such bacteria is of immense importance.

AmpC producing K. pneumoniae have been increasingly reported from India but epidemiological studies are lacking.[7],[8],[9],[10],[11] In the present study, molecular epidemiology of AmpC producing clinical isolates of K. pneumoniae prevalent in our hospital was studied using sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) whole-cell protein profile analysis and ribotyping.

 Materials and Methods



Bacterial strains

A total of 51 non-repeat, consecutive, clinical isolates of K. pneumoniae recovered from patients at the University College of Medical Sciences and Guru Tegh Bahadur Hospital, during August to October 2002, were included in the study. These included 14 isolates from blood cultures, 12 from urine, five from sputum, two from cerebrospinal fluid, eight from surgical wound swabs and 10 from burns wound swabs. The isolates were identified as K. pneumoniae by using standard biochemical tests.[12]

Antimicrobial susceptibility testing

The antimicrobial susceptibility testing was carried out using standard disk diffusion technique using current NCCLS recommendations.[13] Commercially available antibiotic discs (HiMedia, Mumbai, India) of various antibiotics viz: cefotaxime (30 mg), ceftazidime (30 mg), ceftriaxone (30 mg), cefoxitin (30 mg), aztreonam (30 mg), amoxycillin + clavulanate (20/10 mg), gentamicin (10 mg), amikacin (10 mg), ciprofloxacin (5 mg), were used. Antibiotic disks of imipenem (30 mg) and cefotetan (30 mg) were procured from Oxoid, UK. Quality control was achieved by using a standard strain of E. coli ATCC 25922.

Detection of AmpC enzymes

All the isolates that showed decreased susceptibility to cefoxitin (zone diameter K. pneumoniae , kindly supplied by Wyeth Laboratories, New York, USA.

Isolates found to harbour AmpC enzymes, were subjected to strain typing by whole cell protein profile analysis and ribotyping.

SDS-PAGE whole-cell protein profiling

The whole-cell proteins were extracted from the AmpC producing isolates of K. pneumoniae and subjected to SDS-PAGE using previously described methodology.[14],[15] The gels were stained using Coomasie blue. The wet gels were scanned using red filter with an optically enhanced (420 oe) scanning densitometer (pdi, USA) and the digitized gel images were stored in the computer for analysis.

Ribotyping

The DNA from the isolates was extracted and used for ribotyping using previously described method.[16],[17] Briefly, about 5mg of the isolated DNA was completely digested with 20U of Eco RI and the DNA fragments were separated by agarose gel electrophoresis. Digoxigenin-labeled DNA molecular weight marker II (Boehringer Mannheim, Germany) was included in each gel. These bands were transferred to a nylon membrane by southern blotting (capillary transfer) and probed using a digoxigenin - labeled cDNA probe. Hybrids on the membrane were detected by an enzyme immunoassay using alkaline phosphatase-conjugated anti-digoxigenin antibodies and colour substrate mixture of nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) substrates. All these steps were performed in accordance with the instructions in the DIG system user guide for filter hybridization (Boehringer Manneheim, Germany).

Computerized numerical analysis of protein and ribo- patterns was performed using the diversity Database® software (version 1.1) incorporated into a gel documentation system (pdi, USA). Cluster analysis of the patterns was done using the unweighted - pair group method with arithmetic averages - UPGMA. Even one band difference in protein profiles or ribo-patterns was taken as significant difference and the isolates were treated as different clones.

The discriminatory power of the two techniques was calculated using numerical index called Index of Discrimination (ID), which is based on the probability that two unrelated strains sampled from the test population will be placed into different typing groups.[18] This probability was calculated by the following equation:

[INLINE:1] Where N is the total number of strains, s is the total number of types and nj is the number of strains belonging to the jth type.

 Results



Epidemiological details of isolates are summarized in the table. Whole cell protein profiles of these isolates had 32 to 38 protein bands [Figure 1].

The dendrogram based on the similarity values of the protein profiles is shown in [Figure 2]. Protein fingerprinting revealed six different types of protein profiles (P1 - P6). Protein type P6 was the largest cluster with six isolates.

Ribo-patterns and the dendrogram based on similarity values of these patterns are shown in [Figure 3] and [Figure 4] respectively.

The E co RI enzyme generated well-separated band patterns, which were easy to interpret because of moderate number of restricted DNA fragments (8 to 15) and their even distribution. The molecular weights of the fragments ranged between 20 to 0.5 kbp. Ribotyping could further discriminate between the strains that were clustered by protein fingerprinting. Twelve different types of ribo-patterns were identified. The technique showed that all AmpC producing isolates of K. pneumoniae were distinct clones except in one instance (ribo-pattern R12). Ribotyping was found to have a higher DI (0.98) than that of SDS-PAGE (0.78).

Multidrug resistance (three or more drugs) was observed in 90% (n=46) of the isolates. Resistance to aminoglycosides was high, with as many as 72% (n=37) of the isolates showing resistance to gentamicin and 69% (n=35) to amikacin. Decreased susceptibilities to cefotetan and cefoxitin were observed among 51% (n=26) and 43% (n=22) of the isolates respectively. Of the 26 isolates that showed decreased susceptibility to cefoxitin and/or cefotetan 13 isolates were found to harbour AmpC enzyme.

 Discussion



The present study demonstrates that most of the patients at our hospital were infected with distinct clones of ESACs. Origin of these ESACs could not be identified in our study. Presence of multiple clones of ESACs indicates that there was no patient-to-patient hospital transmission. Major risk factors for colonization or infection with ESACs have been shown to be long term antibiotic exposure, prolonged hospital stay, severe illness, residence in an institution with high rates of ceftazidime and other third generation cephalosporins usage and instrumentation or catheterization.[18],[19],[20] It has been shown in several studies that alimentary canal of patients gets colonized with such strains which then spread to the site of infection through the oro-faecal route.[21] Our study thus, points to the fact that several clones of AmpC harbouring K. pneumoniae were circulating in our hospital and these were involved in causing infection in different patients. Isolation of three AmpC positive clones from three patients of OPD is indicative of the extent of circulation of such strains in the community. All the hospitalized patients from whom isolates producing AmpC enzymes were isolated had a history of intake of antibiotics. Unfortunately, history of antibiotic intake of OPD isolates was not available. This data emphasized the need of stricter implementation of antibiotic policy in the hospital and the need of continuous surveillance of antimicrobial resistance among the hospital and community isolates to curb the emergence and spread of ESACs.

SDS-PAGE whole-cell protein profile analysis was used for the first time by Costas et al , for typing clinical isolates of Klebsiella aerogenes.[14] The protein patterns were reported to be highly reproducible and were used as the basis of numerical analysis, which divided the clinical isolates into various protein types. It was concluded that high-resolution SDS-PAGE of proteins provides an effective adjunct to other methods for typing isolates of K. aerogenes . SDS-PAGE whole cell protein profiling has never been used earlier for typing of AmpC producing K. pneumoniae isolates. Our study is the first study of its kind in which this technique has been evaluated. The technique was able to discriminate between the unrelated strains with DI of 0.78.

Only a few studies on ribotyping of K. pneumoniae for delineation of the epidemiology are available in the literature. In a study, 14 clinical isolates of K. pneumoniae , isolated from different hospitals of France between 1987 and 1989, were subjected to different typing techniques including ribotyping.[22] Ribotyping with Eco RI and Hin dIII and genomic fingerprinting with Xba 1 by PFGE were concordant and suggested that 12 of the isolates recovered from the 14 hospitals were probably the same strain.

In the present study, ribotyping could identify two strains belonging to the same clone (R12). Protein fingerprinting also clustered these two isolates in one protein type (P6). Both of these isolates were obtained from the burns ward with a gap of almost three weeks. The source of infection could not be identified. It can be concluded that majority of patients in our hospital were infected with different clones and there was no evidence of patient to patient transmission during the period of this study.

The study also demonstrated the usefulness of SDS-PAGE and ribotyping as epidemiologic typing techniques; the latter being more discriminatory.

References

1Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae . Antimicrob Agents Chemother 1990; 34 :2200-9.
2Gazouli M, Kaufmann ME, Tzelepi E, Dimopoulou H, Paniara O, Tzouvelekis LS. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J Clin Microbiol 1997; 35 :508-10.
3M'Zali FH, Heritage J, Gascoyne-Binzi DM, Denton M, Todd NJ, Hawkey PM. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. J Antimicrob Chemother 1997; 40 :823-31.
4Horii T, Arakawa Y, Ohta M, Ichiyama S, Wacharotayankun R, Kato N. Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam. Antimicrob Agents Chemother 1993; 37 :984-90.
5Philippon A, Arlet G, Jacoby GA. Plasmid-Determined AmpC-Type beta-lactamases. Antimicrobial Agents Chemother 2002; 46 :1-11.
6Barnaud G, Labia R, Raskine L, Sanson-Le Pors MJ, Philippon A, Arlet G. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol Lett 2001; 195 :185-90.
7Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 2003; 51 :415-8.
8Subha A, Devi VR, Ananthan S. AmpC beta-lactamase producing multidrug resistant strains of Klebsiella spp. & Escherichia coli isolated from children under five in Chennai . Indian J Med Res 2003; 117 :13-8.
9Shahid M, Malik A, Sheeba. Multidrug-resistant Pseudomonas aeruginosa strains producing R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India. FEMS Microbiol Lett 2003; 228 :181-6.
10Ratna AK, Menon I, Kapur I, Kulkarni R. Occurrence & detection of AmpC beta-lactamases at a referral hospital in Karnataka. Indian J Med Res 2003; 118 :29-32.
11Aubert D, Girlich D, Naas T, Nagarajan S, Nordmann P. Functional and structural characterization of the genetic environment of an extended-spectrum beta-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob Agents Chemother 2004; 48 :3284-90.
12Crichton PB. Enterobacteriaceae: Escherichia, Klebsiella, Proteus and other genera. In : Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie & McCartney Practical Medical Microbiology , 14th ed. (Churchill Livingstone: Edinburgh, UK) 1996: 361-84.
13National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th informational supplement. National Committee for Clinical Laboratory Standards: Wayne, Pennsylvania; 2000. M100-S10.
14Costas M, Holmes B, Sloss LL. Comparison of SDS-PAGE protein patterns with other typing methods for investigating the epidemiology of ' Klebsiella aerogenes' . Epidemiol Infect 1990; 104 :455-65.
15Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227 :680-5.
16Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28 :495-503.
17Haertl R, Barten R, Bandlow G. Epidemiological fingerprinting of Klebsiella pneumoniae by small-fragment-restriction-endonuclease-analysis (SF-REA). Scand J Infect Dis 1991; 23 :737-43.
18Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: An application of Simpson's index of diversity. J Clin Microbiol 1988; 26 :2465-6.
19Rice LB. Successful interventions for gram-negative resistance to extended spectrum beta-lactamase antibiotics. Pharmacotherapy 1999; 19 :120S-8S.
20Pena C, Pujol M, Ricart A, Ardanuy C, Ayats J, Linares J, et al . Risk factors for fecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in intensive care unit. J Hosp Infect 1997; 35 :9-16.
21Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae : risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32 :1162-71.
22Arlet G, Rouveau M, Casin I, Bouvet PJ, Lagrange PH, Philippon A. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol 1994; 32 :2553-8.